Celyad Oncology SA DPO Ratio 2011-2026 | CYAD

Annual DPO Ratio Celyad Oncology SA

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	55.8 K	3.13 M	-	-	-	-

All numbers in EUR currency

Maximum	Minimum	Average
3.13 M	55.8 K	1.59 M

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
AbbVie ABBV	65.5	$ 208.84	-2.86 %	$ 369 B	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	25.8 K	$ 3.33	-2.06 %	$ 99 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Adaptive Biotechnologies Corporation ADPT	35.1	$ 14.81	2.63 %	$ 2.25 B	USA
Amgen AMGN	64.8	$ 347.94	-1.51 %	$ 187 B	USA
ANI Pharmaceuticals ANIP	60.1	$ 74.21	-2.3 %	$ 1.43 B	USA
Aurinia Pharmaceuticals AUPH	47.5	$ 15.61	0.9 %	$ 2.1 B	Canada
Autolus Therapeutics plc AUTL	9.57	$ 1.41	2.17 %	$ 375 M	Britain
Aytu BioScience AYTU	186	$ 2.68	1.52 %	$ 16.8 M	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
BioCryst Pharmaceuticals BCRX	484	$ 9.02	-3.84 %	$ 1.86 B	USA
Axon Enterprise AXON	29.9	$ 412.81	-2.54 %	$ 31.3 B	USA
Alnylam Pharmaceuticals ALNY	55	$ 318.85	-3.01 %	$ 41.8 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel